메뉴 건너뛰기




Volumn 25, Issue 2, 2008, Pages 162-167

Chemotherapy and its effect on liver hypertrophy: Implications for portal vein embolization and resection

Author keywords

Chemotherapy; Colorectal liver metastases; Hepatotoxicity; Portal vein obstruction

Indexed keywords


EID: 46949105694     PISSN: 07399529     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1076682     Document Type: Review
Times cited : (6)

References (45)
  • 2
    • 0034712536 scopus 로고    scopus 로고
    • Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
    • Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000;355:1041-1047
    • (2000) Lancet , vol.355 , pp. 1041-1047
    • Douillard, J.Y.1    Cunningham, D.2    Roth, A.D.3
  • 3
    • 0033874892 scopus 로고    scopus 로고
    • Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
    • De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938-2947
    • (2000) J Clin Oncol , vol.18 , pp. 2938-2947
    • De Gramont, A.1    Figer, A.2    Seymour, M.3
  • 4
    • 2542561964 scopus 로고    scopus 로고
    • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    • Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342
    • (2004) N Engl J Med , vol.350 , pp. 2335-2342
    • Hurwitz, H.1    Fehrenbacher, L.2    Novotny, W.3
  • 5
    • 3242720345 scopus 로고    scopus 로고
    • Cetuximab monotherapy and cetuximab plus irinotecan in irinotecanrefractory metastatic colorectal cancer
    • Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecanrefractory metastatic colorectal cancer. N Engl J Med 2004; 351:337-345
    • (2004) N Engl J Med , vol.351 , pp. 337-345
    • Cunningham, D.1    Humblet, Y.2    Siena, S.3
  • 6
    • 4644320061 scopus 로고    scopus 로고
    • Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival
    • Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004;240:644-657
    • (2004) Ann Surg , vol.240 , pp. 644-657
    • Adam, R.1    Delvart, V.2    Pascal, G.3
  • 7
    • 15744374738 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma
    • Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23:2038-2048
    • (2005) J Clin Oncol , vol.23 , pp. 2038-2048
    • Leonard, G.D.1    Brenner, B.2    Kemeny, N.E.3
  • 8
    • 34548513652 scopus 로고    scopus 로고
    • Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases
    • Nordlinger B, Sorbye H, Collette B, et al. Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. 2007 ASCO Annual Meeting Proceedings Part I. Journal of Clinical Oncology 2007;25(18 suppl)
    • (2007) ASCO Annual Meeting Proceedings Part I. Journal of Clinical Oncology 2007;25(18 suppl)
    • Nordlinger, B.1    Sorbye, H.2    Collette, B.3
  • 9
    • 10044266415 scopus 로고    scopus 로고
    • A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases
    • Jaeck D, Oussoultzoglou E, Rosso E, et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004;240:1037-1049
    • (2004) Ann Surg , vol.240 , pp. 1037-1049
    • Jaeck, D.1    Oussoultzoglou, E.2    Rosso, E.3
  • 10
    • 0037635260 scopus 로고    scopus 로고
    • Right portal vein ligation: A new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases
    • Kianmanesh R, Farges O, Abdalla EK, et al. Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 2003; 197:164-170
    • (2003) J Am Coll Surg , vol.197 , pp. 164-170
    • Kianmanesh, R.1    Farges, O.2    Abdalla, E.K.3
  • 11
    • 0037315694 scopus 로고    scopus 로고
    • Portal vein embolization before right hepatectomy: Prospective clinical trial
    • Farges O, Belghiti J, Kianmanesh R, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003;237:208-217
    • (2003) Ann Surg , vol.237 , pp. 208-217
    • Farges, O.1    Belghiti, J.2    Kianmanesh, R.3
  • 12
    • 0033658667 scopus 로고    scopus 로고
    • Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors
    • Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 2000;232:777-785
    • (2000) Ann Surg , vol.232 , pp. 777-785
    • Adam, R.1    Laurent, A.2    Azoulay, D.3
  • 13
    • 0036269410 scopus 로고    scopus 로고
    • Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization
    • Abdalla EK, Barnett CC, Doherty D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002;137:675-680
    • (2002) Arch Surg , vol.137 , pp. 675-680
    • Abdalla, E.K.1    Barnett, C.C.2    Doherty, D.3
  • 14
    • 33947267189 scopus 로고    scopus 로고
    • Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
    • Zorzi D, Laurent A, Pawlik TM, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007;94:274-286
    • (2007) Br J Surg , vol.94 , pp. 274-286
    • Zorzi, D.1    Laurent, A.2    Pawlik, T.M.3
  • 15
    • 11144354740 scopus 로고    scopus 로고
    • Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
    • Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15:460-466
    • (2004) Ann Oncol , vol.15 , pp. 460-466
    • Rubbia-Brandt, L.1    Audard, V.2    Sartoretti, P.3
  • 16
    • 19744365905 scopus 로고    scopus 로고
    • Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases
    • Fernandez FG, Ritter J, Goodwin JW, et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005;200:845-853
    • (2005) J Am Coll Surg , vol.200 , pp. 845-853
    • Fernandez, F.G.1    Ritter, J.2    Goodwin, J.W.3
  • 17
    • 30144435398 scopus 로고    scopus 로고
    • Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases
    • Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1-7
    • (2006) Ann Surg , vol.243 , pp. 1-7
    • Karoui, M.1    Penna, C.2    Amin-Hashem, M.3
  • 18
    • 33646457231 scopus 로고    scopus 로고
    • Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
    • Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065-2072
    • (2006) J Clin Oncol , vol.24 , pp. 2065-2072
    • Vauthey, J.N.1    Pawlik, T.M.2    Ribero, D.3
  • 19
    • 33745298640 scopus 로고    scopus 로고
    • Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy
    • Beal IK, Anthony S, Papadopoulou A, et al. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy. Br J Radiol 2006;79:473-478
    • (2006) Br J Radiol , vol.79 , pp. 473-478
    • Beal, I.K.1    Anthony, S.2    Papadopoulou, A.3
  • 20
    • 33644504569 scopus 로고    scopus 로고
    • Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction
    • Goere D, Farges O, Leporrier J, et al. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg 2006;10:365-370
    • (2006) J Gastrointest Surg , vol.10 , pp. 365-370
    • Goere, D.1    Farges, O.2    Leporrier, J.3
  • 21
    • 0033637804 scopus 로고    scopus 로고
    • Preoperative systemic 5-fluorouracil does not increase the risk of liver resection
    • Parc Y, Dugué L, Farges O, Hiramatsu K, et al. Preoperative systemic 5-fluorouracil does not increase the risk of liver resection. Hepatogastroenterology 2000;47:1703-1705
    • (2000) Hepatogastroenterology , vol.47 , pp. 1703-1705
    • Parc, Y.1    Dugué, L.2    Farges, O.3    Hiramatsu, K.4
  • 22
    • 13444274825 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases
    • Yedibela S, Elad L, Wein A, et al. Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases. Eur J Surg Oncol 2005;31:141-146
    • (2005) Eur J Surg Oncol , vol.31 , pp. 141-146
    • Yedibela, S.1    Elad, L.2    Wein, A.3
  • 23
    • 33750957147 scopus 로고    scopus 로고
    • Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases
    • Aloia T, Sebagh M, Fiasse M, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006;24:4983-4990
    • (2006) J Clin Oncol , vol.24 , pp. 4983-4990
    • Aloia, T.1    Sebagh, M.2    Fiasse, M.3
  • 24
    • 33846309211 scopus 로고    scopus 로고
    • Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes
    • Sahajpal A, Vollmer CM, Dixon E, et al. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. J Surg Oncol 2007;95:22-27
    • (2007) J Surg Oncol , vol.95 , pp. 22-27
    • Sahajpal, A.1    Vollmer, C.M.2    Dixon, E.3
  • 25
    • 33846641607 scopus 로고    scopus 로고
    • Preoperative chemotherapy and the outcome of liver resection for colorectal metastases
    • Hewes JC, Dighe S, Morris RW, et al. Preoperative chemotherapy and the outcome of liver resection for colorectal metastases. World J Surg 2007;31:353-364
    • (2007) World J Surg , vol.31 , pp. 353-364
    • Hewes, J.C.1    Dighe, S.2    Morris, R.W.3
  • 26
    • 34347234594 scopus 로고    scopus 로고
    • Preoperative chemotherapy for colorectal liver metastases: Impact on hepatic histology and postoperative outcome
    • Pawlik TM, Olino K, Gleisner AL, et al. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 2007;11:860-868
    • (2007) J Gastrointest Surg , vol.11 , pp. 860-868
    • Pawlik, T.M.1    Olino, K.2    Gleisner, A.L.3
  • 27
    • 33846603686 scopus 로고    scopus 로고
    • Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: A matched case-control study
    • D'Angelica M, Kornprat P, Gonen M, et al. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Ann Surg Oncol 2007;14:759-765
    • (2007) Ann Surg Oncol , vol.14 , pp. 759-765
    • D'Angelica, M.1    Kornprat, P.2    Gonen, M.3
  • 28
    • 10744231437 scopus 로고    scopus 로고
    • Impact of steatosis on perioperative outcome following hepatic resection
    • Kooby DA, Fong Y, Suriawinata A, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003;7:1034-1044
    • (2003) J Gastrointest Surg , vol.7 , pp. 1034-1044
    • Kooby, D.A.1    Fong, Y.2    Suriawinata, A.3
  • 29
    • 0033922244 scopus 로고    scopus 로고
    • Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection
    • Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 2000;191:38-46
    • (2000) J Am Coll Surg , vol.191 , pp. 38-46
    • Belghiti, J.1    Hiramatsu, K.2    Benoist, S.3
  • 30
    • 36348974014 scopus 로고    scopus 로고
    • Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis
    • Gomez D, Malik HZ, Bonney GK, et al. Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 2007;94:1395-1402
    • (2007) Br J Surg , vol.94 , pp. 1395-1402
    • Gomez, D.1    Malik, H.Z.2    Bonney, G.K.3
  • 31
    • 0031781467 scopus 로고    scopus 로고
    • Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer
    • Peppercorn PD, Reznek RH, Wilson P, et al. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer 1998;77:2008-2011
    • (1998) Br J Cancer , vol.77 , pp. 2008-2011
    • Peppercorn, P.D.1    Reznek, R.H.2    Wilson, P.3
  • 32
    • 0029038552 scopus 로고
    • Reversible hepatic steatosis in patients treated with Interferon alfa-2a and 5-fluorouradl
    • Sorensen P, Edal AL, Madsen EL, et al. Reversible hepatic steatosis in patients treated with Interferon alfa-2a and 5-fluorouradl. Cancer 1995;75:2592-2596
    • (1995) Cancer , vol.75 , pp. 2592-2596
    • Sorensen, P.1    Edal, A.L.2    Madsen, E.L.3
  • 33
    • 0027424043 scopus 로고
    • Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy
    • Moertel CG, Fleming TR, Macdonald JS, et al. Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy. J Clin Oncol 1993;11:2386-2390
    • (1993) J Clin Oncol , vol.11 , pp. 2386-2390
    • Moertel, C.G.1    Fleming, T.R.2    Macdonald, J.S.3
  • 34
    • 0023552434 scopus 로고
    • Veno-occlusive disease of the liver following bone marrow transplantation
    • Jones RJ, Lee KS, Beschorner WE, et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987;44:778-783
    • (1987) Transplantation , vol.44 , pp. 778-783
    • Jones, R.J.1    Lee, K.S.2    Beschorner, W.E.3
  • 35
    • 0036899613 scopus 로고    scopus 로고
    • Hepatic veno-occlusive disease in blood and bone marrow transplantation in children and young adults: Incidence, risk factors, and outcome in a cohort of 241 patients
    • Reiss U, Cowan M, McMillan A, et al. Hepatic veno-occlusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients. J Pediatr Hematol Oncol 2002;24:746-750
    • (2002) J Pediatr Hematol Oncol , vol.24 , pp. 746-750
    • Reiss, U.1    Cowan, M.2    McMillan, A.3
  • 36
    • 0022485314 scopus 로고
    • Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma
    • Takayasu K, Muramatsu Y, Shima Y, et al. Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma. Radiology 1986;160:389-393
    • (1986) Radiology , vol.160 , pp. 389-393
    • Takayasu, K.1    Muramatsu, Y.2    Shima, Y.3
  • 37
    • 0025255473 scopus 로고
    • Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report
    • Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990;107:521-527
    • (1990) Surgery , vol.107 , pp. 521-527
    • Makuuchi, M.1    Thai, B.L.2    Takayasu, K.3
  • 38
    • 0034126372 scopus 로고    scopus 로고
    • Resection of non-resectable liver metastases from colorectal cancer after percutaneous portal vein embolization
    • Azoulay D, Castaing D, Smail A, et al. Resection of non-resectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000;231:480-486
    • (2000) Ann Surg , vol.231 , pp. 480-486
    • Azoulay, D.1    Castaing, D.2    Smail, A.3
  • 39
    • 33748931490 scopus 로고    scopus 로고
    • Improving resectability of hepatic colorectal metastases: Expert consensus statement
    • Abdalla EK, Adam R, Bilchik AJ, et al. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13:1271-1280
    • (2006) Ann Surg Oncol , vol.13 , pp. 1271-1280
    • Abdalla, E.K.1    Adam, R.2    Bilchik, A.J.3
  • 40
    • 0030710208 scopus 로고    scopus 로고
    • Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors
    • Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997;26:1176-1181
    • (1997) Hepatology , vol.26 , pp. 1176-1181
    • Kubota, K.1    Makuuchi, M.2    Kusaka, K.3
  • 41
    • 0032965124 scopus 로고    scopus 로고
    • Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume
    • Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999;188:304-309
    • (1999) J Am Coll Surg , vol.188 , pp. 304-309
    • Shirabe, K.1    Shimada, M.2    Gion, T.3
  • 42
    • 46949101878 scopus 로고    scopus 로고
    • Bouzari H, Amisano M, Zorzi D, et al. Hypertrophy of the future liver remnant following portal vein occlusion: portal vein embolization vs portal vein ligation. HPB 2006;8(suppl 2):27-28
    • Bouzari H, Amisano M, Zorzi D, et al. Hypertrophy of the future liver remnant volume following portal vein occlusion: portal vein embolization vs portal vein ligation. HPB 2006;8(suppl 2):27-28
  • 43
    • 46149095353 scopus 로고    scopus 로고
    • Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant
    • Aussilhou B, Lesurtel M, Sauvanet A, et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 2008;12:297-303
    • (2008) J Gastrointest Surg , vol.12 , pp. 297-303
    • Aussilhou, B.1    Lesurtel, M.2    Sauvanet, A.3
  • 44
    • 46949097677 scopus 로고    scopus 로고
    • Gruenberger T, Tamandl D, Puhalla H, et al. Bevacizumab plus XELOX as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. 2007 ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007; 25(suppl):4064
    • Gruenberger T, Tamandl D, Puhalla H, et al. Bevacizumab plus XELOX as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. 2007 ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007; 25(suppl):4064
  • 45
    • 0027471469 scopus 로고
    • Early use of cisplatin is safe after partial hepatectomy
    • Engum SA, Sidner RA, Miller GA, et al. Early use of cisplatin is safe after partial hepatectomy. J Pediatr Surg 1993; 28:411-417
    • (1993) J Pediatr Surg , vol.28 , pp. 411-417
    • Engum, S.A.1    Sidner, R.A.2    Miller, G.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.